MedTrace Logo

Adherence Trial With MS LifeLines ® Services

NCT01905527 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 306

Last updated 2015-02-02

No results posted yet for this study

Summary

This is a Phase IV study to compare the current level of MS LifeLines ® (MSLL) services (face-to-face nursing visits and phone contacts) with customized MSLL services, to determine the optimal services to enhance medication adherence and treatment persistence with Rebif ® subcutaneous three times a week.

Conditions

Interventions

OTHER

Standard Services of Group A (Group A1)

Support services provided in this group will include: Initial field nurse injection training visit; field nurse follow-up and subsequent visits; and follow-up phone calls at periodic intervals

OTHER

Customized Services of Group A (Group A2)

In addition to the initial field nurse injection training visit and follow-up call, subjects will select from support services including field nurse follow-up visits; follow-up phone calls; email and/or text reminders; subject self-assessment and use of treatment planning tools; and mail/e-mail educational materials.

OTHER

Group B

Support services provided in this group will include initial field nurse injection training visit and follow-up phone calls at periodic intervals.

Sponsors & Collaborators

Principal Investigators

  • Medical Responsible · EMD Serono, an affiliate of Merck KGaA, Darmstadt, Germany

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-07-31
Primary Completion
2015-01-31
Completion
2015-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01905527 on ClinicalTrials.gov